-
1.发明授权公开(公告)号：US10716775B2
公开(公告)日：2020-07-21
申请号：US15619860
申请日：2017-06-12
IPC分类号： A61K31/22 , A61K31/351 , A61K45/06 , A61K31/232 , A61K31/202 , A61K31/366 , A61K31/40 , A61K31/225
摘要： Disclosed is a composition which is useful for preventing the occurrence of a cardiovascular event, particularly a composition which is expected to show a prophylactic effect on a cardiovascular event occurring in a hypercholesterolemia patient despite providing the patient with a treatment with HMG-CoA RI or a cardiovascular event occurring in a multiple risk patient.
-
2.发明授权Composition and/or method for preventing onset and/or recurrence of cardiovascular events 有权用于预防心血管事件发作和/或复发的组合物和/或方法公开(公告)号：US09198892B2
公开(公告)日：2015-12-01
申请号：US13672405
申请日：2012-11-08
发明人： Mitsuhiro Yokoyama , Hideki Origasa , Masunori Matsuzaki , Yuji Matsuzawa , Yasushi Saito , Yuichi Ishikawa , Shinichi Oikawa , Jun Sasaki , Hitoshi Hishida , Hiroshige Itakura , Toru Kita , Akira Kitabatake , Noriaki Nakaya , Toshiie Sakata , Kazuyuki Shimada , Kunio Shirato
IPC分类号： A61K31/232 , A61K9/48
CPC分类号： A61K31/202 , A61K9/0053 , A61K9/48 , A61K31/232
摘要： Provided are composition and/or methods useful in preventing onset and/or recurrence of cardiovascular events, especially in patients who have escaped the unstable period after cardiovascular angioplasty or in hyperlipidemia patients who have been treated with HMG-CoA RI.
摘要翻译： 提供用于预防心血管事件的发作和/或复发的组合物和/或方法，特别是在已经在心血管血管成形术后不稳定时期或在用HMG-CoA RI治疗的高脂血症患者中的患者中。
-
3.发明授权公开(公告)号：US09700537B2
公开(公告)日：2017-07-11
申请号：US15431958
申请日：2017-02-14
IPC分类号： A61K31/232 , A61K31/40 , A61K31/366 , A61K31/225 , A61K31/202 , A61K31/22 , A61K31/351
CPC分类号： A61K31/22 , A61K31/202 , A61K31/225 , A61K31/232 , A61K31/351 , A61K31/366 , A61K31/40 , A61K45/06 , A61K2300/00
摘要： Disclosed is a composition which is useful for preventing the occurrence of a cardiovascular event, particularly a composition which is expected to show a prophylactic effect on a cardiovascular event occurring in a hypercholesterolemia patient despite providing the patient with a treatment with HMG-CoA RI or a cardiovascular event occurring in a multiple risk patient.
-
公开(公告)号：US09539230B2
公开(公告)日：2017-01-10
申请号：US14432012
申请日：2013-09-19
发明人： Masahiko Ohta , Shinichi Oikawa , Mitsuhiro Yokoyama , Hideki Origasa , Masunori Matsuzaki , Yuji Matsuzawa , Yasushi Saito
IPC分类号： A61K31/202 , A61K31/232
CPC分类号： A61K31/202 , A61K31/232
摘要： A medical composition for reducing the rate of new-onset diabetes caused by administration of a statin or for inhibiting an increase in blood glucose level by administration of a statin, the composition containing at least one ingredient selected from the group consisting of icosapentaenoic acid and pharmaceutically acceptable salts or esters thereof as an inactive ingredient.
摘要翻译： 一种用于降低由他汀类药物给药引起的新发糖尿病发病率或通过给予他汀类药物抑制血糖水平升高的药物组合物，所述组合物含有选自二十碳五烯酸和药学上的至少一种成分 可接受的盐或酯作为无活性成分。
-
公开(公告)号：US20150250754A1
公开(公告)日：2015-09-10
申请号：US14432012
申请日：2013-09-19
发明人： Masahiko Ohta , Shinichi Oikawa , Mitsuhiro Yokoyama , Hideki Origasa , Masunori Matsuzaki , Yuji Matsuzawa , Yasushi Saito
IPC分类号： A61K31/202
CPC分类号： A61K31/202 , A61K31/232
摘要： A medical composition for reducing the rate of new-onset diabetes caused by administration of a statin or for inhibiting an increase in blood glucose level by administration of a statin, the composition containing at least one ingredient selected from the group consisting of icosapentaenoic acid and pharmaceutically acceptable salts or esters thereof as an inactive ingredient.
摘要翻译： 一种用于降低由他汀类药物给药引起的新发糖尿病发病率或通过给予他汀类药物抑制血糖水平升高的药物组合物，所述组合物含有选自二十碳五烯酸和药学上的至少一种成分 可接受的盐或酯作为无活性成分。
-
-
-
-
搜索结果
5 条记录 (耗时 0.014 秒)
